Search

everythinglearnresearchcommunity

for

Search:↓

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Etanercept may not prevent alopecia areata from coming back.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

New therapies are being developed that target integrin pathways to treat various diseases.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Mogamulizumab can cause hair loss and skin rashes.

Stress hormone corticosterone suppresses hair growth by affecting stem cell activity and Gas6 protein expression.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

MicroRNA-21 could help diagnose and treat skin fibrosis.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Certain growth factors significantly affect hair loss in women with telogen effluvium.